Literature DB >> 18954319

Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells.

Masahiko Ayaki1, Shigeo Yaguchi, Atsuo Iwasawa, Ryohei Koide.   

Abstract

PURPOSE: The cytotoxicity of a range of commercial ophthalmic solutions in the presence and absence of preservatives was assessed in human corneal endothelial cells (HCECs), corneal epithelia and conjunctival epithelia using in vitro techniques.
METHODS: Cell survival was measured using the WST-1 assay for endothelial cells and the MTT assay for epithelial cells. Commercially available timolol, carteolol, cromoglicate, diclofenac, bromfenac and hyaluronic acid ophthalmic solutions were assessed for cytotoxicity in the presence and absence of preservatives. The preservatives benzalkonium, chlorobutanol and polysorbate were also tested. The survival of cells exposed to test ophthalmic solutions was expressed as a percentage of cell survival in the control solution (distilled water added to media) after 48 h exposure.
RESULTS: HCEC survival was 20-30% in ophthalmic solutions diluted 10-fold. The survival of HCEC was significantly greater in all solutions in the absence of preservative than in the presence of preservative. The survival of corneal and conjunctival epithelia was consistent with that of HCECs for all test ophthalmic solutions. The preservatives polysorbate and benzalkonium were highly cytotoxic with cell survival decreasing to 20% at the concentration estimated in commercial ophthalmic solutions. By comparison, the survival of cells exposed to chlorobutanol was 80% or greater.
CONCLUSIONS: The cytotoxicity of ophthalmic solutions to HCEC, corneal epithelia and conjunctival epithelia decreased in the absence of preservative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18954319     DOI: 10.1111/j.1442-9071.2008.01803.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  28 in total

1.  Apoptotic effects of norfloxacin on corneal endothelial cells.

Authors:  Ting-Jun Fan; Shu-Xian Wu; Guo-Jian Jiang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-16       Impact factor: 3.000

2.  Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty.

Authors:  Osman Sevki Arslan; Ceyhun Arici; Mustafa Unal; Erdogan Cicik; Mehmet Serhat Mangan; Eray Atalay
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?

Authors:  D Lockington; E C A Macdonald; P Stewart; D Young; M Caslake; K Ramaesh
Journal:  Eye (Lond)       Date:  2012-03-02       Impact factor: 3.775

4.  Management strategies for persistent epithelial defects of the cornea.

Authors:  Lee R Katzman; Bennie H Jeng
Journal:  Saudi J Ophthalmol       Date:  2014-07-02

5.  Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells.

Authors:  Kazuhide Kawase; Wenzhong Lin; Yumiko Aoyama; Tetsuya Yamamoto; Masamitsu Shimazawa; Hideaki Hara
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

6.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

7.  Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines.

Authors:  Masahiko Ayaki; Atsuo Iwasawa
Journal:  Clin Ophthalmol       Date:  2010-08-19

8.  Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Yoichi Inoue
Journal:  Clin Ophthalmol       Date:  2010-10-21

9.  In vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells.

Authors:  Ana Guzman-Aranguez; Patricia Calvo; Inés Ropero; Jesús Pintor
Journal:  J Ocul Pharmacol Ther       Date:  2014-08-06       Impact factor: 2.671

10.  Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components.

Authors:  Patrícia Abreu Ferreira da Cunha; Flavio Araujo Shinzato; Geraldine Trevisan Tecchio; Sarah La Porta Weber; Alexandre Brasil; Amaryllis Avakian
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.